Hair loss is a common side effect of cancer treatment and can be psychologically distressing.
As a result, many patients choose to try various solutions on their own to restore hair growth.
One of the most commonly used supplements is biotin, a vitamin found in everyday foods, and deficiency is rare.
Nevertheless, many people take it as a supplement, often based on advice from the internet or acquaintances.
Also read: These jobs provide the most steps in daily life
According to SciTechDaily, this applies to more than half of patients experiencing hair loss.
Issues with tests
Research from Ohio State University, published in JCO Oncology Practice, shows that biotin can affect blood tests.
This includes tests used to monitor the progression of several types of cancer.
Biotin can interfere with measurements, making results misleading. Some values may appear lower than they actually are, while others may appear higher.
Also read: Simple eye test could help detect Alzheimer’s sooner
This can lead doctors to make decisions based on incorrect information or to delay treatment.
There are also indications that biotin may affect measurements used when heart problems are suspected, making it more difficult to establish an accurate diagnosis.
Better alternatives
Researchers point out that there are safer ways to manage hair loss. One example is the drug minoxidil, which is approved and used to promote hair growth.
At the same time, researchers emphasize the importance of patients consulting their doctor before starting dietary supplements.
Also read: Is turkey bacon healthier than regular bacon? Here’s what the research says
This can help prevent complications during treatment.
Biotin not only lacks documented effectiveness against hair loss but may also interfere with critical aspects of cancer treatment.
Sources: SciTechDaily and JCO Oncology Practice.
Also read: This happens in your body if you eat ketchup every day
Also read: Donald Trump’s granddaughter Kai Trump had to seek urgent medical attention during a golf tournament
This article is made and published by Ida-Marie Palm Varbæk, who may have used AI in the preparation.